You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In Science this week: environmental influences on the protein-coding genome of marine microbes, and more.
NPR reports that CDC officials were aware of problems with its initial SARS-CoV-2 test before the test was sent out.
Spectrum reports that a clinical trial of a gene therapy for Angelman syndrome is on hold.
Denmark reacts to a mutated SARS-CoV-2 strain found among minks also being detected in a dozen people, the Associated Press reports.
Stuff reports that genomic testing has linked a case of COVID-19 affecting a New Zealand healthcare worker to a quarantined group.
Science reports on how scientists running for office in the US have fared in the election, though some results are still being counted
The Associated Press reports South Korea has approved a test that detects both the SARS-CoV-2 and seasonal influenza viruses.
In Nature this week: sequence of the Gala apple and two of its wild relatives, analysis of SARS-CoV-2 genomes highlights role of US travelers and superspreaders in transmission in Israel, and more.
Slovakia tested about two-thirds of its population for SARS-CoV-2 last weekend, finding just more than 1 percent of the population was positive, NPR reports.
According to Stat News, US regulators appear to have a favorable view of Biogen's Alzheimer's disease therapy.
The Guardian reports that AstraZeneca and Oxford University's coronavirus vaccine will likely not be ready for distribution by late December.
In Cell this week: SARS-CoV-2 evolution and spread in North Carolina, protein and other features that distinguish mild and severe COVID-19, and more.
A pilot program for mass COVID-19 testing is to start in Liverpool, Sky News reports.
An analysis suggests rapid SARS-CoV-2 tests may have drawbacks under real-world conditions, the New York Times reports.
The Scientist reports a blood test for Alzheimer's disease is now available in many US states.
In PNAS this week: genetic diversity and more among Nipah viruses, glycome expression study of the brain, and more.
The New York Times had geneticists sequence SARS-CoV-2 samples from two journalists who contracted the virus while covering the White House.
Three US agencies warn of ransomware attacks aimed at hospitals, CBS News reports.
The Guardian writes that researchers are examining whether small genetic changes account for the different COVID-19 disease courses people experience.
In PLOS this week: gene expression in muscle stem cells, blood metabolomic study of diabetic retinopathy complications, and more.
The strain now accounts for about 80 percent of cases in Wales and Scotland, and about half of cases in England, the Guardian reports.
The Washington Post reports that US states and territories are seeking more funding for the distribution of SARS-CoV-2 vaccines.
A new study suggests that using CRISPR to edit human embryonic DNA can lead to the loss of whole chromosomes, as the Associated Press reports.
In Science this week: ancient dog genomes highlight long ties with humans, genomic analysis of 40,000-year-old early East Asian individual, and more.
NPR reports that some insect pests are now becoming resistant to Bt crops.
Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.
23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.
The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.
In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.